We believe that if even a single patient feels the need to turn to potentially unsafe and unapproved knockoff alternatives, that's one too many," said Dave Moore, Executive Vice President, US Operations of Novo Nordisk Inc
Setting realistic expectations is crucial, as weight loss is a gradual journey
Share your relevant health history including current conditions, previous weight loss attempts, and what hasnt worked
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications with specific licensed indications in the UK
For several years now, Ive been using low-dose GLP-1 in patients who had nothing to do with weight loss: patients with MCAS, chemical sensitivity, POTS, alpha-gal syndrome
At full therapeutic doses, semaglutide produces meaningful weight loss